Search

Because They Can

Updated: Apr 2, 2018

by Alexis Young


Twelve-year-old Rick retrieves a coconut bar. At least he thought that’s what he has. But as soon as he bites into, chews, and swallows a hunk of the bar, his body reacts violently with hives, chest pains, and swelling that threatens to close his windpipe. Of the two similar boxes standing side by side in that pantry, he had mistakenly picked the wrong one and grabbed a peanut bar. Rick has a life-threatening allergy to peanuts.


Fortunately, Rick also has an EpiPen, and the swift injection saves his life.


Sue, a middle-aged woman also has an extreme allergy to peanuts but can no longer afford the EpiPen that escalated in price from $100 to $600. She has to be extremely cautious, scrutinizing ingredients, always alert for contamination of products or equipment. She cannot afford to make Rick’s mistake.


The story of the mammoth jump in price of EpiPen and the rationalizations of Mylan, the company that alone carries the patent of that injector of the drug, epinephrine, continue to make news. People are outraged at the blatant profit-making move of the company. In a probable effort to appease the seething public and its customers, Mylan recently announced the advent of its own generic version of the EpiPen to arrive on the market soon, only to cost $300.


How can Mylan or any pharmaceutical company unilaterally make such a decision? On what basis? Here we’re not talking about recreational items, nonessential gadgets…we’re talking about prescribed drugs that are necessary to maintain or improve one’s health, or save one’s life.


The simplest answer to the how is — because they can.


But we’ll flesh out that succinct answer and in following columns delve into several major causes that contribute to the high and rising costs of prescription drugs. We’ll look at the lack of price controls, lengthy patent times (and how companies navigate to extend those patents), the takeover of companies that produce generics, extensive and aggressive marketing, the lack of transparency within companies and their middlemen (e.g., pharmacy benefits managers), limited competition, and the situation in other countries. We’ll also suggest what we can do to change what we believe is unjust.


The we behind Health Matters, a new monthly column, are members of the Health Care Access Coalition, a grassroots group with members from the local community as well as students of St. Bonaventure University, many who are pre-med students in the Franciscan Health Care Program.  As a coalition we are committed to promoting affordable, comprehensive and quality health care for all through education and advocacy. We’ve taken the high cost of prescription drugs as our first focus.

1 view

Recent Posts

See All

Code Red, Code Blue, Code Crazy

by Kristin Chambers Imagine you make your living crafting gorgeous pottery bowls, mugs, and plates. You know precisely what your materials cost and how many hours are required to create your products.

Wishes Can Become Reality

By Athena Godet-Calogeras ’Tis the season to make a wish list — or several. For kids the sky’s the limit; for adults the focus more often centers on real, practical and tangible needs. I’ve composed a

Caregivers Need Care

By Athena Godet-Calogeras Several years ago when stressed because I couldn’t do more for my mother who was suffering from lung cancer and dementia, I blurted out to a friend, “I just want her to have

Contact Us

Athena Godet-Calogeras
3629 Five Mile Rd.

Allegany, NY 14706
Telephone & Fax: 716.372.3348
Email: hcac@mail.com

Connect with us

© 2018 by Health Care Access Coalition.

  • Black Facebook Icon